Calpain-like and lactate dehydrogenase activities in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis

Neurochemical Journal

Volumn 1, Issue 4, 2007, Pages 326-333

  Brylev, L V ^a,b   Yakovlev, A A ^b   Onufriev, M V ^b   Zakharova, M N ^a   Zavalishin, I A ^a   Gulyaeva, N V ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

^b INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

Calpain; Cerebrospinal fluid; Lactate dehydrogenase; Later alamyotrophic sclerosis; Neurodegeneration

Indexed keywords

EID: 37749007579     PISSN: 18197124     EISSN: 18197132     Source Type: Journal    
DOI: 10.1134/S1819712407040101     Document Type: Article

References (34)

1. Shaw, P.J., J. Neurol. Neurosurg. Psychiatry, 2005, vol. 76, pp. 1046-1057.
2. Zavalishin, I.A, and Zakharova, M.N., General Mechanisms of Development of Pathological Process during Neurodegenerative Disease and Ageing, in Neirodegenerativnye bolezni i starenie (Neurodegenerative Diseases and Ageing), Moscow, 2001, pp. 354-399.
3. Zakharova, M.N., Amyotrophic Lateral Sclerosis and Oxidative Stress, Doctoral (Med.) Dissertation, 2001.
4. Amyotrophic Lateral Sclerosis, Mitsumoto, H., Przedborski, S., and Gordon, P.H., Eds., London: Taylor Francis, 2006, pp. 339-354.
5. Ranganathan, S. and Bowser, R., Am. J. Pathol., 2003, vol. 162, no. 3, pp. 823-835.
6. Lim, A.C. and Qi, R.Z., J. Alzheimers. Dis., 2003, vol. 5, no. 4, pp. 329-335.
7. Nguyen, M.D., Boudreau, M., Kriz, J., et al., J. Neurosci., 2003, vol. 15, pp. 2131-2140.
8. Siman, R., McIntosh, T., Soltesz, K., et al., Neurobiol. Dis., 2004, vol. 16, pp. 311-320.
9. Dengler, R., von Neuhoff, N., Bufler, J., et al., J. Neurodegener. Dis., 2005, vol. 2, nos. 3-4, pp. 177-184.
10. Ranganathan, S., Williams, E., Ganchev, P., et al., J. Neurochem., 2005, vol. 95, no. 5, pp. 1451-1471.
11. Bowser, R., Cudkowicz, M., and Kaddurah-Daouk, R, Expert. Rev. Mol. Diagn., 2006, vol. 6, no. 3, pp. 387-398.
12. Kolarcik, C. and Bowser, R., Mol. Diagn. Ther., 2006, vol. 10, no. 5, pp. 281-292.
13. Niebroj-Dobosz, I., Jamrozik, Z., Janik, P., et al., Acta Neurol. Scand., 1999, vol. 100, no. 4, pp. 238-243.
14. Niebroj-Dobosz, I., Dziewulska, D., Janik, P., et al., Folia Neuropathol., 2006, vol. 44, no. 3, pp. 191-196.
15. Ilzecka, J., Stelmasiak, Z., and Dobosz, B., Acta Neurol. Scand., 2001, vol. 103, no. 4, pp. 255-258.
16. Bilic, E., Rudan, I., Kusec, V., et al., Eur. J. Neuron., 2006, vol. 13, no. 12, pp. 1340-1345.
17. Sussmuth, S.D., Tumani, H., Ecker, D., Ludolph, A.C., Neurosci. Lett., 2003, vol. 353, no. 1, pp. 57-60.
18. Mattson, M.P., Antioxid. Redox. Signal., 2006, vol. 8, nos. 11-12, pp. 1997-2006.
19. Culmsee, C. and Landshamer, S., Curr. Alzheimer Res., 2006, vol. 3, no. 4, pp. 269-283.
20. Hook, V.Y., Biodrugs, 2006, vol. 20, no. 2, pp. 105-119.
21. Beuche, W., Yushchenko, M., Mader, M., et al., Neuroreport, 2000, vol. 11, no. 16, pp. 3419-2322.
22. Lorenzl, S., Albers, D.S., LeWitt, P.A., et al., J. Neurol. Sci., 2003, vol. 297, nos. 1-2, pp. 71-76.
23. Saez, M. E., Ramirez-Lorca, R., Moron, F.J., and Ruiz, A., Drug Discov. Today, 2006, vol. 19-20, pp. 917-923.
24. Camins, A., Verdaguer, E., Folch, J., and Pallas, M., CNS Drug Rev., 2006, vol. 12, no. 2, pp. 135-148.
25. EL Escorial, World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis, J. Neurol. Sci., 1994, vol. 134(suppl.), pp. 96-107.
26. Khodkarian, O.A., Bunina, T.L., and Zavalishin, I.A., Bokovoi amiotroficheskii skleroz (Amyotrophic Lateral Sclerosis), Moscow: Meditsina, 1978.
27. Norris, F.H., Amyotrophic Lateral Sclerosis: The Clinical Disorder, Smith, R.A., Ed., New York: Marcel Dekker, 1992, pp. 3-38.
28. ALS CNTF Treatment Study (ACTS) Phase I-II Study Group: The Amyotrophic Lateral Sclerosis Functional Rating Scale, Arch. Neurol., 1996, vol. 53, pp. 141-147.
29. Mitsumoto, H., Chad, D.A., and Pioro, E.P., Amyotrophic Lateral Sclerosis, Philadelphia: Davis Company, 1998, pp. 151-164.
30. Bradford, M.M., Anal. Biochem., 1976, vol. 72, pp. 248-252.
31. Lases, E.C., van Loon, D., de Bie, M., et al., Clin. Chim. Acta, 2004, vol. 346, pp. 221-223.
32. Bizat, N., Hermel., J.M., Boyer, F., et al., J. Neurosci., 2003, vol. 23, pp. 5020-5030.
33. Beuche, W., Yushchenko, M., Mader, M., et al., J. Neuroimmunol., 2000, vol., 110, nos. 1-2, pp. 244-251.
34. Edmunds, T., Nagainis, P.A., Sathe., S.K., et al., Biochim. Biophys. Acta, 1991, vol. 1077, pp. 187-208.